Trial Profile
Treating Acutely Agitated Patients With Asenapine Sublingual Tablets: A Single-Dose, Randomized, Double-Blind Placebo Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Asenapine (Primary)
- Indications Agitation
- Focus Therapeutic Use
- 19 Nov 2015 New trial record